This Everest Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Author: Avi Kapoor | January 30, 2025 09:10am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Goldman Sachs analyst Kate McShane downgraded the rating for Floor & Decor Holdings, Inc. (NYSE:FND) from Neutral to Sell and maintained the price target of $79. Floor & Decor shares closed at $102.13 on Wednesday. See how other analysts view this stock.
William Blair analyst Sami Corwin downgraded CARGO Therapeutics, Inc. (NASDAQ:CRGX) from Outperform to Market Perform. Cargo Therapeutics shares closed at $13.19 on Wednesday. See how other analysts view this stock.
Wells Fargo analyst Mohit Bansal downgraded the rating for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) from Overweight to Equal-Weight and maintained the price target of $460. Vertex Pharmaceuticals shares closed at $441.52 on Wednesday. See how other analysts view this stock.
HSBC analyst Vikram Gandhi downgraded KKR & Co. Inc. (NYSE:KKR) from Buy to Hold but raised the price target from $153 to $173. KKR shares closed at $166.30 on Wednesday. See how other analysts view this stock.
BMO Capital analyst Michael Zaremski downgraded the rating for Everest Group, Ltd. (NYSE:EG) from Outperform to Market Perform and lowered the price target from $453 to $375. Everest Group shares closed at $351.51 on Wednesday. See how other analysts view this stock.
Considering buying EG stock? Here’s what analysts think:
